Harlan DM - Search Results

1

Pancreatic beta cell function persists in many patients with chronic type 1 diabetes, but is not dramatically improved by prolonged immunosuppression and euglycaemia from a beta cell allograft.

Liu EH, Digon BJ 3rd, Hirshberg B, Chang R, Wood BJ, Neeman Z, Kam A, Wesley RA, Polly SM, Hofmann RM, Rother KI, Harlan DM. Liu EH, et al. Among authors: harlan dm. Diabetologia. 2009 Jul;52(7):1369-80. doi: 10.1007/s00125-009-1342-7. Epub 2009 May 6. Diabetologia. 2009. PMID: 19418039 Free PMC article. Clinical Trial.

2

Challenges facing islet transplantation for the treatment of type 1 diabetes mellitus.

Rother KI, Harlan DM. Rother KI, et al. Among authors: harlan dm. J Clin Invest. 2004 Oct;114(7):877-83. doi: 10.1172/JCI23235. J Clin Invest. 2004. PMID: 15467822 Free PMC article.

3

Assessment of islet function following islet and pancreas transplantation.

Dy EC, Harlan DM, Rother KI. Dy EC, et al. Among authors: harlan dm. Curr Diab Rep. 2006 Aug;6(4):316-22. doi: 10.1007/s11892-006-0067-y. Curr Diab Rep. 2006. PMID: 16879785 Free PMC article. Review.

4

Effects of exenatide alone and in combination with daclizumab on beta-cell function in long-standing type 1 diabetes.

Rother KI, Spain LM, Wesley RA, Digon BJ 3rd, Baron A, Chen K, Nelson P, Dosch HM, Palmer JP, Brooks-Worrell B, Ring M, Harlan DM. Rother KI, et al. Among authors: harlan dm. Diabetes Care. 2009 Dec;32(12):2251-7. doi: 10.2337/dc09-0773. Epub 2009 Oct 6. Diabetes Care. 2009. PMID: 19808924 Free PMC article. Clinical Trial.

5

Benefits and risks of solitary islet transplantation for type 1 diabetes using steroid-sparing immunosuppression: the National Institutes of Health experience.

Hirshberg B, Rother KI, Digon BJ 3rd, Lee J, Gaglia JL, Hines K, Read EJ, Chang R, Wood BJ, Harlan DM. Hirshberg B, et al. Among authors: harlan dm. Diabetes Care. 2003 Dec;26(12):3288-95. doi: 10.2337/diacare.26.12.3288. Diabetes Care. 2003. PMID: 14633816 Clinical Trial.

6

Radiologic aspects of islet cell transplantation.

Neeman Z, Hirshberg B, Harlan D, Wood BJ. Neeman Z, et al. Curr Diab Rep. 2006 Aug;6(4):310-5. doi: 10.1007/s11892-006-0066-z. Curr Diab Rep. 2006. PMID: 16879784 Free PMC article. Review.

7

Resistin serum levels in type 1 diabetes pre- and post-islet transplantation.

Shalev A, Patterson NB, Hirshberg B, Rother KI, Harlan DM. Shalev A, et al. Among authors: harlan dm. Metabolism. 2004 Apr;53(4):403-4. doi: 10.1016/j.metabol.2003.11.014. Metabolism. 2004. PMID: 15045683

8

Pancreatic islet cell therapy for type I diabetes: understanding the effects of glucose stimulation on islets in order to produce better islets for transplantation.

Ren J, Jin P, Wang E, Liu E, Harlan DM, Li X, Stroncek DF. Ren J, et al. Among authors: harlan dm. J Transl Med. 2007 Jan 3;5:1. doi: 10.1186/1479-5876-5-1. J Transl Med. 2007. PMID: 17201925 Free PMC article. Review.

9

Islet transplantation and the challenges of treating type 1 diabetes.

Liu EH, Rother KI, Harlan DM. Liu EH, et al. Among authors: harlan dm. Discov Med. 2005 Feb;5(25):43-9. Discov Med. 2005. PMID: 20704922 Free article.

10

Uncoupling intensive insulin therapy from weight gain and hypoglycemia in type 1 diabetes.

Brown RJ, Wijewickrama RC, Harlan DM, Rother KI. Brown RJ, et al. Among authors: harlan dm. Diabetes Technol Ther. 2011 Apr;13(4):457-60. doi: 10.1089/dia.2010.0159. Epub 2011 Feb 28. Diabetes Technol Ther. 2011. PMID: 21355723 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

169 results

Search Page

Filters